Comparison of [177Lu-DOTA0,Tyr3]octreotate and [177Lu-DOTA0,Tyr3]octreotide: which peptide is preferable for PRRT?

Jan-Paul Esser, E. P. Krenning, Jaap J.M. Teunissen, P.P.M. Kooij, A. L. H. van Gameren, Willem H. Bakker, Dik J. Kwekkeboom

European Journal of Nuclear Medicine and Molecular Imaging · 2006 · 179 citations · 13 references

Concepts

References

13